THYROCAREHealthcare Service Provider
Thyrocare Technologies Ltd — PE Ratio & Valuation Analysis
₹349.55
-2.13%
Current P/E60.48xPrice to earnings
Industry P/E39.28xSector average
4Y Avg P/E41.4x45.9% above avg
⚠️
54.0% Premium to Industry
THYROCARE P/E 60.48x vs sector avg 39.28x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹17.23 | ₹446 | 25.9x |
| 2024 | ₹13.34 | ₹912 | 68.3x |
| 2023 | ₹12.14 | ₹644 | 53x |
| 2022 | ₹33.25 | ₹619 | 18.6x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Thyrocare Technologies Ltd Valuation
Thyrocare Technologies Ltd (THYROCARE) currently trades at 60.48x earnings. The Healthcare Service Provider sector average PE is 39.28x. THYROCARE commands a premium, reflecting high growth expectations. Historically, THYROCARE has traded at an average PE of 41.4x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
16.15%
Dividend Yield
1.44%
More on Thyrocare Technologies Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.